"We are MercyOne: a connected system of health care facilities and services dedicated to helping you live your best life."

During the past decade, Ruan Neurology Clinic and Research Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ruan Neurology Clinic and Research Center" #1 sponsor was "TauRx Therapeutics Ltd" with 2 trials, followed by "Acorda Therapeutics" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Fred Lublin" with 1 trials sponsored and "Genzyme, a Sanofi Company" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ruan Neurology Clinic and Research Center" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "The University of Texas Health Science Center, Houston" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Ruan Neurology Clinic and Research Center" are "Alzheimer's Disease" (2 trials), "Behavioral Variant Frontotemporal Dementia" (1 trials), "Multiple Sclerosis" (1 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials) and "Relapsing Remitting Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Ruan Neurology Clinic and Research Center" in a lesser frequency.

Most popular intervention types in "Ruan Neurology Clinic and Research Center" are "Drug" (6 trials), "Other" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "ASA 100 mg" (1 trials), "Alemtuzumab 12 mg" (1 trials), "Alemtuzumab 24 mg" (1 trials) and "Dalfampridine-ER 10mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ruan Neurology Clinic and Research Center" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Ruan Neurology Clinic and Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Ruan Neurology Clinic and Research Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Ruan Neurology Clinic and Research Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".